Federal Trade Commission v. Novant Health, Inc. et al
Case Number:
5:24-cv-00028
Court:
Nature of Suit:
15:0045 Federal Trade Commission Act
Judge:
Firms
- Ballard Spahr
- Clifford Chance
- Crowell & Moring
- Dechert LLP
- Epstein Becker
- Fitzgerald Hanna
- Flannery Georgalis
- Fox Rothschild
- Gallivan White
- Gibson Dunn
- Husch Blackwell
- Lincoln Derr
- Morgan Lewis
- Nelson Mullins
- Parker Poe
- Robinson Bradshaw
- Rule Garza
- Williams & Connolly
- Williams Mullen
- Womble Bond
- Wyrick Robbins
- Zelle LLP
Companies
- Aetna Inc.
- Atrium Health
- CaroMont Health Inc.
- Centene Corp.
- Morgan Stanley
- Novant Health Inc.
- The Cigna Group
Government Agencies
Sectors & Industries:
-
June 11, 2024
FTC Gets Short Extension On Novant Deal Pause
A North Carolina federal court Tuesday extended an order preventing Novant Health from closing its $320 million deal for a pair of hospitals in the state by 10 days to give the Federal Trade Commission time to ask the Fourth Circuit to pause the transaction.
-
June 10, 2024
FTC To Fight Go-Ahead Order On Novant $320M Hospital Deal
Just days after a district court loss, the Federal Trade Commission said Monday it will ask the Fourth Circuit to step in and block Novant Health from buying two North Carolina hospitals in a $320 million deal the agency contends would harm competition.
-
June 05, 2024
FTC Can't Pause Novant's $320M Bid To Buy NC Hospitals
The Federal Trade Commission on Wednesday lost its bid to block Novant Health from buying two local hospitals in North Carolina for $320 million while it conducts an in-house review, with a federal judge reasoning that competition would actually fare better if the merger advanced.
-
May 30, 2024
FTC, Novant Ask To Delay In-House Trial On Merger Challenge
The Federal Trade Commission and Novant Health have asked to postpone an upcoming administrative hearing over the nonprofit's proposed purchase of two North Carolina hospitals, a purchase that regulators are concerned will dampen competition in the region, according to a noticeĀ filed in federal court.
-
May 07, 2024
Novant CEO Vows To Improve Hospitals Facing FTC Scrutiny
Novant Health kicked off its defense Tuesday in the Federal Trade Commission's $320 million merger challenge with testimony from its longtime CEO, who vocalized the health system's promise to reinvest in the two struggling hospitals at the center of the case.
-
May 03, 2024
Hospital In Novant Merger Beset By Staff Turnover, Court Told
The Federal Trade Commission and two healthcare companies used witness testimony Friday to paint competing pictures of a North Carolina hospital at the center of a $320 million merger dispute: one in which the hospital has focused on making quality improvements, and another where it's been plagued by poor ratings and high staff turnover.
-
May 01, 2024
Future Is 'Bleak' If Judge Rejects Novant Merger, Court Hears
Novant Health on Wednesday sought to portray itself as the "last best hope" to save two struggling hospitals in North Carolina at the start of a multiday hearing in which the Federal Trade Commission is asking the court to squelch Novant's proposed $320 million merger.
-
April 30, 2024
FTC Says Novant Wants Court To Ignore Local Competition
Novant Health can't ask a federal judge to ignore evidence that buying two North Carolina hospitals will stymie competition in the region just because those facilities are supposedly struggling and the proposed deal might shore up resources, the Federal Trade Commission said in a brief doubling down on its bid to block the $320 million buyout.
-
April 25, 2024
NC Hospital Leader Condemns FTC's Merger Block Bid
The chief of staff for a North Carolina hospital in the midst of a merger battle ripped the care facility's current owners Thursday in a show of support for new ownership, pleading for federal antitrust regulators to get out of the way lest they usher in "a year long death marked by suffering" for the hospital.
-
April 16, 2024
NC Treasurer Backs FTC On Hospital Merger Challenge
North Carolina's treasurer agreed Monday that Novant Health's $320 million plan to pick up a pair of hospitals is a bad idea, throwing its weight behind the Federal Trade Commission's challenge to the deal in federal court.